Bank of Montreal
BMO
Canadian Imperial Bank of Commerce
CM
Bank of Nova Scotia
BNS
Royal Bank of Canada
RY
The Toronto-Dominion Bank
TD
CA Stock MarketDetailed Quotes
DOSE Rapid Dose Therapeutics Corp
- 0.185
- 0.0000.00%
15min DelayMarket Closed Feb 14 15:27 ET
23.76MMarket Cap-4.63P/E (TTM)
0.185High0.180Low7.21KVolume0.180Open0.185Pre Close1.31KTurnover0.32552wk High0.01%Turnover Ratio128.44MShares0.12052wk Low-0.04EPS TTM21.26MFloat Cap1.330Historical HighLossP/E (Static)114.91MShs Float0.025Historical Low-0.04EPS LYR2.70%Amplitude--Dividend TTM-5.78P/B1Lot Size--Div YieldTTM
Rapid Dose Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Nov 30, 2024 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 114.57%501.69K | 46.08%515.92K | 65.70%398.99K | 42.06%1.02M | -11.36%192.65K | -23.50%233.81K | 164.44%353.17K | 289.84%240.79K | -59.00%718.3K | 49.07%217.35K |
| Operating revenue | 114.57%501.69K | 46.08%515.92K | 65.70%398.99K | 42.06%1.02M | -11.36%192.65K | -23.50%233.81K | 164.44%353.17K | 289.84%240.79K | -59.00%718.3K | 49.07%217.35K |
| Cost of revenue | 121.57%231.36K | 72.05%187.92K | 15.51%142.29K | 32.13%457.02K | -53.44%87.86K | 33.62%104.42K | 124.38%109.23K | 305.56%123.18K | -15.04%345.89K | -17.79%188.7K |
| Gross profit | 108.92%270.33K | 34.45%328K | 118.28%256.7K | 51.29%563.41K | 265.76%104.8K | -43.12%129.4K | 187.42%243.95K | 274.62%117.61K | -72.31%372.4K | 134.22%28.65K |
| Operating expense | 39.23%1.29M | 66.37%1.19M | 100.21%1.21M | -7.03%3.64M | 5.44%1.25M | 21.78%924.45K | -25.67%712.56K | -40.06%604.85K | -30.65%3.92M | -56.90%1.19M |
| Selling and administrative expenses | 78.00%1.19M | 94.46%1.11M | 151.85%1.1M | -17.95%2.6M | -7.40%749.43K | 9.33%671.24K | -36.13%570.44K | -48.73%436.26K | -29.95%3.17M | -64.59%809.3K |
| -Selling and marketing expense | 14.70%209.97K | 22.56%133.73K | 143.50%228.96K | -14.86%241.7K | -154.08%-67.35K | 555.36%183.06K | 45.10%109.12K | 68.00%94.03K | -4.12%283.89K | -49.55%124.54K |
| -General and administrative expense | 101.74%984.84K | 111.47%975.54K | 154.14%869.75K | -18.26%2.36M | 19.28%816.78K | -16.70%488.18K | -43.59%461.32K | -56.95%342.23K | -31.76%2.88M | -66.41%684.76K |
| Research and development costs | -56.07%44.09K | 1,240.49%26.02K | 33.68%29.52K | 360.57%427.8K | 351.53%303.41K | 202.76%100.37K | 103.88%1.94K | -48.10%22.08K | -74.15%92.89K | -59.61%67.2K |
| Depreciation amortization depletion | -68.49%48.16K | -64.18%50.22K | -43.53%82.73K | -1.14%620.31K | -27.09%207.25K | 36.46%152.84K | 21.28%140.19K | 26.75%146.51K | -18.07%627.44K | -7.59%284.26K |
| -Depreciation and amortization | -68.49%48.16K | -64.18%50.22K | -43.53%82.73K | -1.14%620.31K | -27.09%207.25K | 36.46%152.84K | 21.28%140.19K | 26.75%146.51K | -18.07%627.44K | -7.59%284.26K |
| Provision for doubtful accounts | ---- | ---- | ---- | -145.89%-5.97K | ---- | ---- | ---- | ---- | --13K | ---- |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --15.62K | ---- |
| Operating profit | -27.88%-1.02M | -82.99%-857.51K | -95.85%-954.25K | 13.16%-3.08M | 0.98%-1.15M | -49.54%-795.05K | 46.37%-468.62K | 50.16%-487.25K | 17.62%-3.54M | 59.17%-1.16M |
| Net non-operating interest income (expenses) | -238.97%-347.76K | -38.94%-242.15K | -281.80%-304.03K | -149.94%-661.45K | -115.80%-304.95K | -97.86%-102.59K | -327.70%-174.28K | -159.11%-79.63K | -98.80%-264.64K | -297.35%-141.31K |
| Non-operating interest expense | 238.97%347.76K | 38.94%242.15K | 281.80%304.03K | 149.94%661.45K | 115.80%304.95K | 97.86%102.59K | --174.28K | 159.11%79.63K | 98.26%264.64K | 297.89%141.31K |
| Other net income (expenses) | -35,162.05%-567.72K | -87.78K | 99.96%-1.61K | |||||||
| Gain on sale of security | ---- | ---- | ---- | -453.11%-8.91K | ---- | ---- | ---- | ---- | -106.73%-1.61K | ---- |
| Special income (charges) | ---- | ---- | ---- | ---558.81K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | --558.81K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---87.78K | ---- | ---- | ---- |
| Income before tax | -52.01%-1.36M | -50.50%-1.1M | -121.97%-1.26M | -13.03%-4.31M | -55.10%-2.02M | -53.84%-897.64K | 20.10%-730.69K | 43.79%-566.88K | 55.11%-3.81M | 81.18%-1.3M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -52.01%-1.36M | -50.50%-1.1M | -121.97%-1.26M | -13.03%-4.31M | -55.10%-2.02M | -53.84%-897.64K | 20.10%-730.69K | 43.79%-566.88K | 55.11%-3.81M | 81.18%-1.3M |
| Net income continuous operations | -52.01%-1.36M | -50.50%-1.1M | -121.97%-1.26M | -13.03%-4.31M | -55.10%-2.02M | -53.84%-897.64K | 20.10%-730.69K | 43.79%-566.88K | 55.11%-3.81M | 81.18%-1.3M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -39.08%-1.36M | -50.50%-1.1M | -121.97%-1.26M | -13.03%-4.31M | -57.57%-2.05M | -68.14%-981.08K | 20.10%-730.69K | 43.79%-566.88K | 55.11%-3.81M | 81.18%-1.3M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -39.08%-1.36M | -50.50%-1.1M | -121.97%-1.26M | -13.03%-4.31M | -57.57%-2.05M | -68.14%-981.08K | 20.10%-730.69K | 43.79%-566.88K | 55.11%-3.81M | 81.18%-1.3M |
| Diluted earnings per share | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.04 | 37.50%-0.01 | -66.67%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 50.00%-0.04 | 75.38%-0.016 |
| Basic earnings per share | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.04 | 37.50%-0.01 | -66.67%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 50.00%-0.04 | 75.38%-0.016 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending Stocks
Big Five Big Five
The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.